Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Mar;48(3):1244-1245.
doi: 10.1038/s41440-024-02090-y. Epub 2025 Jan 15.

Prognosis of treatment-resistant hypertension by medication adherence

Tsuguru Hatta  1
Affiliations
Editorial

Prognosis of treatment-resistant hypertension by medication adherence

Tsuguru Hatta. Hypertens Res. 2025 Mar.
No abstract available

Keywords: Apparent treatment-resistant hypertension; Medication Adherence; Treatment-Resistant Hypertension.

PubMed Disclaimer

Conflict of interest statement

Compliance with ethical standards. Conflict of interest: 4 lecture fees. Eli Lilly Japan, Ltd. Nippon Boehringer Ingelheim Co.LTD. AstraZeneca Pharmaceuticals, Inc. Ono Pharmaceutical Industries, Ltd.

Comment on

References

    1. Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, et al. Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association. Hypertension. 2018;72:e53–e90. - DOI - PubMed
    1. Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation. 2012;125:1635–42. - DOI - PubMed - PMC
    1. Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235–481. - DOI - PubMed
    1. Lee CJ, Lee H, Seo J, Hwang J, Kang D, Park SH, et al. Prognosis of apparent treatment-resistant hypertension and poor adherence: a nationwide cohort study. Hypertens Res. 2025;48:49–59. - DOI - PubMed

LinkOut - more resources